TARGETWATCH
SOSobi
Latest price
463.20 SEK
22/07/2026
Latest
515.00 SEK
+11.18%
Upside
3 mo
515.60 SEK
+11.31%
Upside
SOBI
3 mo+11.31%10 price targets
6 mo+11.01%11 price targets
1 yr+9.85%12 price targets
Max 26 price targets
Deutsche BankSEBPareto SecuritiesHC WainwrightDanske BankDNB CarnegieBerenbergExane BNP ParibasBarclaysHandelsbanken
HealthcareDrug Manufacturers—Specialty & Generic

About The Company

Swedish Orphan Biovitrum (Sobi) is a pharmaceutical company with two focus areas: haemophilia and rare diseases. Sobi is a merger of Swedish Orphan and Biovitrum. The company has its premises in Karolinska Institutet Science Park in Solna.
Wikipedia

Latest Target

Target
515.00 SEK
Upside
+11.18%
Latest price463.20 SEK

Insider Trades for Sobi

No insider trades for the selected period.

More Price Targets for Sobi

Date
Jul 21

Analyst
Date
Jul 17

Date
Jul 17

Date
Jul 17

Date
Jul 17

Date
Jul 17

Analyst
Date
Jul 17

Date
Jul 6

Analyst
Date
Jul 3

Date
Jun 11

Analyst
Date
Mar 27

Date
Jan 8

Analyst
Date
Jul -25

Date
Apr -25

Analyst
Date
Apr -25

Analyst
Date
Oct -24

Date
Oct -24

Date
Sep -24

Date
Jul -24

Date
Feb -24

Date
Nov -23

Analyst
Date
Oct -23

Date
Jul -23

Date
Apr -23

Date
Sep -22